Precigen Inc (PGEN) Stock Price, Quote & News

Company Profile

Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious diseases. It operates through two segments, Biopharmaceuticals and Exemplar. The company offers therapeutic platforms consisting of AdenoVerse platform, which utilizes a library of proprietary adenovectors for gene delivery of therapeutic effectors, immunomodulators, and vaccine an...

Industry: Biotechnology

Sector: Healthcare

Phone: 301 556 9900

Website: precigen.com

Address:

20374 Seneca Meadows Parkway, Germantown, United States

Cascas007 Sep. 20 at 4:33 PM

$PGEN based on form 4. Kirk acquired 17M and sold 5M to pay taxes. So he is a net buyer. All signs point to a sale in few months. Most likely after filing for EU approval

1 · Reply

Norny44 Sep. 20 at 2:30 PM

$PGEN it looked like Friday close that 5m were exchanged in unison with a single buyer with absolutely no movement in sp ?. Is that possible?.

1 · Reply

Bordeaux17 Sep. 20 at 1:52 PM

$PGEN Flips his preferreds into 17M commons and sells 5M for lunch money 😎

1 · Reply

JoycelynAnsell471 Sep. 20 at 1:32 PM

$PGEN Breaking from a long-term base pattern. Volume confirming the move. Relative strength improving versus biotech sector.

0 · Reply

Wacousta Sep. 20 at 1:18 PM

$PGEN Latest Form 4 https://investors.precigen.com/static-files/a905460f-7c17-40a9-ac4a-85ea44296555

1 · Reply

Wacousta Sep. 20 at 1:15 PM

$PGEN 13D Amendment https://investors.precigen.com/static-files/745584b1-9dbb-4df5-a441-6addb88659b2

1 · Reply

Cat651 Sep. 19 at 9:39 PM

$PGEN We will see 6,xx next week. If someone changed bonds for shrs,,,is totally fair to say climb stair price just starting cause he knows a lot more than many institutions….Very

1 · Reply

Wacousta Sep. 19 at 9:09 PM

$PGEN FYI https://investors.precigen.com/node/14521/html

0 · Reply

Norny44 Sep. 19 at 8:10 PM

$PGEN looks like those 5m shares just exchanged hands????

1 · Reply

Norny44 Sep. 19 at 8:07 PM

$PGEN Wtf was that volume last 5 mins????

0 · Reply

Precigen Announces Up to $125 Million Non-Dilutive Financing

Sep 2, 2025, 1:55 PM EDT - 18 days ago

Precigen, Inc. - Special Call

Aug 25, 2025, 8:05 AM EDT - 26 days ago

Precigen to Participate in Upcoming Virtual Fireside Chats Hosted by Cantor and H.C. Wainwright

Aug 22, 2025, 10:43 AM EDT - 4 weeks ago

Undercovered Dozen: Precigen, ONEOK, Bitmine And More

BMNR OKE

Aug 15, 2025, 3:15 PM EDT - 5 weeks ago

Precigen: This Billion-Dollar Approval Is Still Undervalued

Aug 15, 2025, 9:48 AM EDT - 5 weeks ago

Why Is Precigen Stock Surging On Friday?

Aug 15, 2025, 7:18 AM EDT - 5 weeks ago

US FDA approves Precigen's immunotherapy for rare respiratory disease

Aug 15, 2025, 7:00 AM EDT - 5 weeks ago

Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis

Jul 7, 2025, 5:58 PM EDT - 2 months ago

Precigen: August Is Pivotal For This Biotech Innovator

May 14, 2025, 4:05 PM EDT - 4 months ago

Precigen Reports First Quarter 2025 Financial Results and Business Updates

Apr 16, 2025, 8:05 AM EDT - 5 months ago

Precigen and Recurrent Respiratory Papillomatosis Foundation to Host the 2025 International RRP Awareness Day on June 11th

Mar 19, 2025, 7:47 PM EDT - 6 months ago

Precigen, Inc. (PGEN) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 4:05 PM EDT - 6 months ago

Precigen Reports Full Year 2024 Financial Results and Business Updates

Mar 13, 2025, 8:05 AM EDT - 6 months ago

Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th

Feb 28, 2025, 8:56 AM EST - 7 months ago

Precigen: UltraCAR-T Development Brings Another Side Of Pipeline Advancement

Feb 25, 2025, 8:05 AM EST - 7 months ago

FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025

Jan 13, 2025, 7:00 AM EST - 8 months ago

Precigen to Present Plans for Realizing Commercial Vision for PRGN-2012 at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 9, 2025, 8:30 AM EST - 9 months ago

Precigen to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 30, 2024, 7:00 AM EST - 9 months ago

Precigen Completes Submission of BLA with Request for Priority Review to the FDA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis

Dec 27, 2024, 9:00 AM EST - 9 months ago

Precigen Announces $79.0 Million Private Placement Offering of Convertible Preferred Stock

Nov 14, 2024, 4:30 PM EST - 11 months ago

Precigen Reports Third Quarter 2024 Financial Results and Business Updates

Nov 12, 2024, 4:05 PM EST - 11 months ago

Precigen to Participate in the Stifel 2024 Healthcare Conference

Sep 16, 2024, 4:30 PM EDT - 1 year ago

Precigen to Participate in the 2024 Cantor Global Healthcare Conference

Aug 15, 2024, 8:11 AM EDT - 1 year ago

Titan Machinery Reports Weak Preliminary Results, Joins Precigen, Gogoro And Other Big Stocks Moving Lower In Thursday Pre-Market Session

GGR TITN

Aug 14, 2024, 7:03 PM EDT - 1 year ago

Precigen, Inc. (PGEN) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:05 PM EDT - 1 year ago

Precigen Reports Second Quarter and First Half 2024 Financial Results and Business Updates

Aug 9, 2024, 8:00 AM EDT - 1 year ago

Precigen to Announce Second Quarter and First Half 2024 Financial Results on August 14th

Aug 7, 2024, 9:30 PM EDT - 1 year ago

Precigen Announces Pricing of $30.0 Million Public Offering of Common Stock

Aug 6, 2024, 4:04 PM EDT - 1 year ago

Precigen Announces Proposed $30 Million Public Offering of Common Stock

Aug 6, 2024, 4:01 PM EDT - 1 year ago

Precigen Strategically Prioritizes Portfolio to Focus on First Potential Gene Therapy Launch

Jul 23, 2024, 8:01 AM EDT - 1 year ago

Precigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy Launch

Jun 3, 2024, 9:30 AM EDT - 1 year ago

Precigen Announces Groundbreaking Pivotal Study Data for PRGN-2012 in Patients with Recurrent Respiratory Papillomatosis in Which More than Half of Patients Achieved Complete Response

May 23, 2024, 5:00 PM EDT - 1 year ago

Precigen to Host a Webcast on June 3rd to Detail Pivotal Study Results of PRGN-2012 in Recurrent Respiratory Papillomatosis Presented at the 2024 ASCO Annual Meeting

May 14, 2024, 4:05 PM EDT - 1 year ago

Precigen Reports First Quarter 2024 Financial Results and Business Updates

May 8, 2024, 4:05 PM EDT - 1 year ago

Precigen to Announce First Quarter 2024 Financial Results on May 14th and Host a Conference Call on June 3rd following the Late-breaking Oral Presentation for PRGN-2012 at the 2024 ASCO Annual Meeting

Apr 24, 2024, 10:20 AM EDT - 1 year ago

Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting

Apr 24, 2024, 9:00 AM EDT - 1 year ago

Actym Therapeutics Appoints Thomas Smart as CEO

ANAB XOMA

Mar 28, 2024, 4:05 PM EDT - 1 year ago

Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th

Mar 19, 2024, 8:49 PM EDT - 1 year ago

Precigen, Inc. (PGEN) Q4 2023 Earnings Call Transcript

Mar 19, 2024, 4:05 PM EDT - 1 year ago

Precigen Reports Full Year 2023 Financial Results and Business Updates

Mar 12, 2024, 4:05 PM EDT - 1 year ago

Precigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis

Mar 5, 2024, 4:05 PM EST - 1 year ago

Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th

Feb 6, 2024, 4:05 PM EST - 1 year ago

Precigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Jan 19, 2024, 7:39 PM EST - 1 year ago

Precigen: RRP Targeting With AdenoVerse Technology Platform

Jan 16, 2024, 8:05 AM EST - 1 year ago

Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission

Jan 8, 2024, 8:30 AM EST - 1 year ago

Precigen Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare Conference

Dec 18, 2023, 4:05 PM EST - 1 year ago

Precigen to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Nov 29, 2023, 4:05 PM EST - 1 year ago

Precigen to Participate in the JMP Securities Hematology and Oncology Summit

Nov 9, 2023, 4:55 PM EST - 2 years ago

Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs

Nov 7, 2023, 4:05 PM EST - 2 years ago

Precigen to Participate in the Stifel 2023 Healthcare Conference

Cascas007 Sep. 20 at 4:33 PM

$PGEN based on form 4. Kirk acquired 17M and sold 5M to pay taxes. So he is a net buyer. All signs point to a sale in few months. Most likely after filing for EU approval

1 · Reply

Norny44 Sep. 20 at 2:30 PM

$PGEN it looked like Friday close that 5m were exchanged in unison with a single buyer with absolutely no movement in sp ?. Is that possible?.

1 · Reply

Bordeaux17 Sep. 20 at 1:52 PM

$PGEN Flips his preferreds into 17M commons and sells 5M for lunch money 😎

1 · Reply

JoycelynAnsell471 Sep. 20 at 1:32 PM

$PGEN Breaking from a long-term base pattern. Volume confirming the move. Relative strength improving versus biotech sector.

0 · Reply

Wacousta Sep. 20 at 1:18 PM

$PGEN Latest Form 4 https://investors.precigen.com/static-files/a905460f-7c17-40a9-ac4a-85ea44296555

1 · Reply

Wacousta Sep. 20 at 1:15 PM

$PGEN 13D Amendment https://investors.precigen.com/static-files/745584b1-9dbb-4df5-a441-6addb88659b2

1 · Reply

Cat651 Sep. 19 at 9:39 PM

$PGEN We will see 6,xx next week. If someone changed bonds for shrs,,,is totally fair to say climb stair price just starting cause he knows a lot more than many institutions….Very

1 · Reply

Wacousta Sep. 19 at 9:09 PM

$PGEN FYI https://investors.precigen.com/node/14521/html

0 · Reply

Norny44 Sep. 19 at 8:10 PM

$PGEN looks like those 5m shares just exchanged hands????

1 · Reply

Norny44 Sep. 19 at 8:07 PM

$PGEN Wtf was that volume last 5 mins????

0 · Reply

erkdg Sep. 19 at 7:07 PM

$PGEN Triple Witching friday today most biotech is down.

0 · Reply

GA09 Sep. 19 at 7:05 PM

$PGEN Randal Kirk sold 5 million shares on 9/18/25. This implies no material discussions taking place internally otherwise he would not be permitted to sell. He still owns 297 million shares. Therefore he sold off a miniscule portion of his holdings. I should have sold @ $5 and bought back today.

0 · Reply

forgottenchuck Sep. 19 at 6:23 PM

$PGEN is there any truth to this because the ceo said last week no dilution?

3 · Reply

Knowledgeworthmore Sep. 19 at 3:06 PM

$PGEN should be 8-9$

0 · Reply

JunkPost Sep. 19 at 2:56 PM

$PGEN $5 Call

0 · Reply

longshort777 Sep. 19 at 2:34 PM

$PGEN. Green candle sometime next week. I’m convinced this is a buy out or major news will drop within the next month

1 · Reply

TS10 Sep. 19 at 1:34 PM

$DPRO $HOTH $PGEN Three potential rippers imo

0 · Reply

Bordeaux17 Sep. 19 at 1:34 AM

$PGEN Alert: OpenAI’s little digital call girl escaped the $INO enclosure and is roaming the $PGEN thread. Someone please grab a leash and escort it back home.

1 · Reply

Golfer109 Sep. 19 at 1:24 AM

$PGEN what I mean for it to come in it's not three and a half or four and a half or five and a half 15 to 30 is the number I want that's what it take over would be $3 a share next year times 10 is 30 that's the value of the stock take over company maybe not pay 30 today maybe they pay 20 to 25 and that would be okay too that's the game we need five or eight or seven yeah it's nice but it's not worth the aggravation we've gone through

1 · Reply

Golfer109 Sep. 19 at 1:21 AM

$PGEN everything is 100% guess but 100% good would be to take an over and then I would never see the stock market again that would be the best of all worlds I'm sure a lot of you guys feel the same way I had two with the losers Aqua Bounty and xylophone so you know this is my chance to get the losses back in a game I'm sure you've all had your shitty problems and shitty stocks only one out of a thousand actually come in this one needs to be the one

0 · Reply

wallstbullinfinity Sep. 19 at 12:13 AM

$PGEN 🚩 Randal Kirk Track Record + Share Sales 📊 Scorecard: 1 win, 1 mixed, 4 flops. And now… Kapital Joe LLC (Kirk’s vehicle) just filed to sell 5M $PGEN shares. ✅ New River (Vyvanse) – sold to Shire for $2.6B (cash/stock exit, Kirk netted >$1B) ⚠️ Intrexon → Precigen – IPO $16 → $70 → <$5. Kapital Joe LLC handled ~6.36M shares in 2018 offering ❌ AquaBounty (GMO salmon) – decades of hype, now penny stock. Kirk/Third Security sold down ~12M shares in secondary; also moved ~8.2M shares via affiliate (TS AquaCulture LLC) ❌ Oxitec (engineered mosquitoes) – never scaled (no big liquidity event) ❌ Ziopharm (Alaunos) – collapsed, bankruptcy 2024. Shares moved in licensing deal (~278K shares) ❌ Okanagan (non-browning apple) – approved but flop (no notable sell data found) https://www.forbes.com/profile/randal-j-kirk/

0 · Reply

Norny44 Sep. 18 at 10:23 PM

$PGEN About a month ago Kirk put forward his own shares and now his son's are put forward??. Is this for easy BO transaction or am I being optimistic??.

0 · Reply

Market Cap	1.13B
Revenue (ttm)	3.93M
Net Income (ttm)	-126.24M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-3,212.21%
Debt to Equity Ratio	0.00

Volume	13,344,800
Avg Vol	9,839,130
Day's Range	N/A - N/A
Shares Out	297.97M
Stochastic %K	36%
Beta	1.82
Analysts	Strong Sell
Price Target	$8.25